[ET Net News Agency, 27 August 2019] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said its profit attributable to owners of the parent was RMB1.52 billion for the
six months ended 30 June 2019, a year-on-year decrease of 2.84%. The earnings per share
were RMB0.59. No dividend will be distributed.
The revenue was RMB14.09 billion, a year-on-year increase of 19.71%. The gross profit
was RMB8.49 billion, a year-on-year increase of 24.42%. (RC)